[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2528837B1 - - Google Patents

Info

Publication number
FR2528837B1
FR2528837B1 FR8210630A FR8210630A FR2528837B1 FR 2528837 B1 FR2528837 B1 FR 2528837B1 FR 8210630 A FR8210630 A FR 8210630A FR 8210630 A FR8210630 A FR 8210630A FR 2528837 B1 FR2528837 B1 FR 2528837B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8210630A
Other languages
French (fr)
Other versions
FR2528837A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERAPEUTIQUE APPLIC SA
Original Assignee
THERAPEUTIQUE APPLIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERAPEUTIQUE APPLIC SA filed Critical THERAPEUTIQUE APPLIC SA
Priority to FR8210630A priority Critical patent/FR2528837A1/en
Priority to CH320483A priority patent/CH657125B/fr
Priority to NL8302087A priority patent/NL8302087A/en
Priority to GR71641A priority patent/GR78284B/el
Priority to DE3321772A priority patent/DE3321772A1/en
Priority to BE0/211031A priority patent/BE897085A/en
Priority to IT8321684A priority patent/IT1194281B/en
Priority to JP58108026A priority patent/JPS5910571A/en
Priority to KR1019830002710A priority patent/KR860001339B1/en
Priority to GB08316516A priority patent/GB2122195A/en
Publication of FR2528837A1 publication Critical patent/FR2528837A1/en
Application granted granted Critical
Publication of FR2528837B1 publication Critical patent/FR2528837B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8210630A 1982-06-18 1982-06-18 ARYLACETYL BUTANOLIDES AND THEIR PYRIDAZINONE DERIVATIVES AS MEDICAMENTS, AND METHODS FOR THEIR MANUFACTURE Granted FR2528837A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (en) 1982-06-18 1982-06-18 ARYLACETYL BUTANOLIDES AND THEIR PYRIDAZINONE DERIVATIVES AS MEDICAMENTS, AND METHODS FOR THEIR MANUFACTURE
CH320483A CH657125B (en) 1982-06-18 1983-06-10
NL8302087A NL8302087A (en) 1982-06-18 1983-06-11 PYRIDAZINOON COMPOUNDS, METHOD FOR THE PREPARATION OF THE SAME AND USE AS A MEDICINAL PRODUCT.
GR71641A GR78284B (en) 1982-06-18 1983-06-13
DE3321772A DE3321772A1 (en) 1982-06-18 1983-06-16 PYRIDAZINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND
BE0/211031A BE897085A (en) 1982-06-18 1983-06-17 PYRIDAZINON DERIVATIVES FOR USE AS MEDICAMENTS AND PROCESSES FOR THEIR MANUFACTURE
IT8321684A IT1194281B (en) 1982-06-18 1983-06-17 PYRIDAZINONE DERIVATIVES THAT CAN BE USED AS MEDICINAL SUBSTANCES AND PROCEDURE FOR THEIR MANUFACTURE
JP58108026A JPS5910571A (en) 1982-06-18 1983-06-17 Medicinal pyridazinone derivatives and manufacture
KR1019830002710A KR860001339B1 (en) 1982-06-18 1983-06-17 Process for preparation of pyridazinone derivatives
GB08316516A GB2122195A (en) 1982-06-18 1983-06-17 Pyridazinones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (en) 1982-06-18 1982-06-18 ARYLACETYL BUTANOLIDES AND THEIR PYRIDAZINONE DERIVATIVES AS MEDICAMENTS, AND METHODS FOR THEIR MANUFACTURE

Publications (2)

Publication Number Publication Date
FR2528837A1 FR2528837A1 (en) 1983-12-23
FR2528837B1 true FR2528837B1 (en) 1984-12-07

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8210630A Granted FR2528837A1 (en) 1982-06-18 1982-06-18 ARYLACETYL BUTANOLIDES AND THEIR PYRIDAZINONE DERIVATIVES AS MEDICAMENTS, AND METHODS FOR THEIR MANUFACTURE

Country Status (10)

Country Link
JP (1) JPS5910571A (en)
KR (1) KR860001339B1 (en)
BE (1) BE897085A (en)
CH (1) CH657125B (en)
DE (1) DE3321772A1 (en)
FR (1) FR2528837A1 (en)
GB (1) GB2122195A (en)
GR (1) GR78284B (en)
IT (1) IT1194281B (en)
NL (1) NL8302087A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
EP0210530A1 (en) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenyl pyridazinones
JPS63220512A (en) * 1987-03-09 1988-09-13 松下電器産業株式会社 Electrode foil for electrolytic capacitor
JPH04100106U (en) * 1991-02-12 1992-08-28
JPH0776050B2 (en) * 1991-07-25 1995-08-16 実 近藤 Work transfer device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (en) * 1973-02-01 1974-08-08 Basf Ag 3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazines

Also Published As

Publication number Publication date
GB8316516D0 (en) 1983-07-20
KR840005105A (en) 1984-11-03
GB2122195A (en) 1984-01-11
BE897085A (en) 1983-12-19
JPS5910571A (en) 1984-01-20
FR2528837A1 (en) 1983-12-23
IT8321684A0 (en) 1983-06-17
NL8302087A (en) 1984-01-16
CH657125B (en) 1986-08-15
IT1194281B (en) 1988-09-14
DE3321772A1 (en) 1983-12-22
GR78284B (en) 1984-09-26
KR860001339B1 (en) 1986-09-15

Similar Documents

Publication Publication Date Title
FR2525127B1 (en)
FR2520952B1 (en)
FR2520951B1 (en)
FR2526101B1 (en)
FR2522007B1 (en)
FR2521328B1 (en)
FR2519689B1 (en)
FR2521244B1 (en)
FR2522514B1 (en)
FR2521939B3 (en)
CH655517B (en)
FR2525281B1 (en)
FR2521987B1 (en)
FR2521294B1 (en)
FR2526592B1 (en)
FR2519673B1 (en)
FR2522296B1 (en)
FR2521651B3 (en)
FR2519612B1 (en)
FR2524716B3 (en)
FR2528837B1 (en)
FR2519951B1 (en)
FR2521933B1 (en)
FR2520588B3 (en)
FR2528844B1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse